The University of Kentucky Markey Cancer Center Research Network (MCCRN) recently awarded Hardin Memorial Health (HMH) Cancer Care Center the 2019 Outstanding Oncology Research Award. The award, presented to the network hospital with the highest patient enrollments in National Cancer Institute (NCI) clinical trials, recognizes HMH Cancer Care’s work to promote and encourage patient participation in oncology research studies.
“We are very proud of our relationship with the Markey Cancer Center Research Network and the insight and resources it provides to our patients,” said Donald Goodin, M.D., Medical Director for HMH Cancer Care. “This award proves we are taking full advantage of the research and NCI-designated opportunities available to HMH Cancer Care patients.”
In 2019, HMH Cancer Care enrolled 25 patients to MCCRN clinical studies developed by Markey physicians and scientists related to population health and cancer control, treatment optimization, efficiency of care, dissemination and implementation, precision medicine and survivorship.
Nationally, HMH Cancer Care is among the top hospitals participating in an NCI National Clinical Trials Network study regarding medicinal intervention for chemotherapy-induced nausea and vomiting. Since October 2018, eight HMH patients have enrolled in this specific clinical trial.
“Our patient’s willingness to help researchers learn more today may help future cancer patients, in Hardin County and beyond, have a better treatment experience,” said Natalie Harper, M.D., Ph.D., HMH Cancer Care Research Director.
As a member of the UK Markey Cancer Center Research Network, HMH conducts studies developed by Markey’s own doctors and scientists, as well as national studies available through Markey’s membership in the NCI’s National Clinical Trials Network.
HMH Cancer Care also joined the UK Markey Cancer Center Affiliate Network in January 2014. The affiliation offers patients access to high-quality cancer services and programs through the state’s only NCI-designated cancer care center. The collaboration gives HMH Cancer Care patients access to the latest treatments, while minimizing travel outside of Central Kentucky.